COVID - 19 Vaccination Update - Day 416 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 39 Second

Posted On: 07 MAR 2022 8:16 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 179 Crore landmark milestone (1,79,09,28,099) today. More than 18 lakh (18,24,967) Vaccine Doses have been administered till 7 pm today. More than 2.07 Crore (2,07,35,818) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10402197
	2^nd Dose	9977321
	Precaution Dose	4256605
FLWs	1^st Dose	18410616
	2^nd Dose	17463033
	Precaution Dose	6403967
Age Group 15-18 years	1^st Dose	55481332
	2^nd Dose	31434778
Age Group 18-44 years	1^st Dose	552710170
Age Group 18-44 years	2^nd Dose	450630396
Age Group 45-59 years	1^st Dose	202425853
Age Group 45-59 years	2^nd Dose	181622958
Over 60 years	1^st Dose	126525204
	2^nd Dose	113108423
	Precaution Dose	10075246
Cumulative 1^st dose administered		965955372
Cumulative 2^nd dose administered		804236909
Precaution Dose		20735818
Total		1790928099

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 7^th March, 2022 (416^th Day)
HCWs	1^st Dose	63
	2^nd Dose	1230
	Precaution Dose	10066
FLWs	1^st Dose	114
	2^nd Dose	2246
	Precaution Dose	14331
Age Group 15-18 years	1^st Dose	73673
	2^nd Dose	464347
Age Group 18-44 years	1^st Dose	105232
Age Group 18-44 years	2^nd Dose	774262
Age Group 45-59 years	1^st Dose	16629
Age Group 45-59 years	2^nd Dose	175309
Over 60 years	1^st Dose	10651
	2^nd Dose	110640
	Precaution Dose	66174
Cumulative 1^st dose administered		206362
Cumulative 2^nd dose administered		1528034
Precaution Dose		90571
Total		1824967

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.